BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND AFF1, MLLT2, 4299, ENSG00000172493, P51825, AF-4, PBM1
8 results:

  • 1. Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study.
    Azam AS; Tsang YW; Thirlwall J; Kimani PK; Sah S; Gopalakrishnan K; Boyd C; Loughrey MB; Kelly PJ; Boyle DP; Salto-Tellez M; Clark D; Ellis IO; Ilyas M; Rakha E; Bickers A; Roberts ISD; Soares MF; Neil DAH; Takyi A; Raveendran S; Hero E; Evans H; Osman R; Fatima K; Hughes RW; McIntosh SA; Moran GW; Ortiz-Fernandez-Sordo J; Rajpoot NM; Storey B; Ahmed I; Dunn JA; Hiller L; Snead DRJ
    Histopathology; 2024 Apr; 84(5):847-862. PubMed ID: 38233108
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hypoxia derived exosomes promote the proliferation and metastasis of colorectal cancer through the regulation of HIF-1α/miR-4299/ZBTB4.
    Wu L; Xue M; Lai S; Chen J; Lin Y; Ding N; Zhong J; Chen S; Wang L
    Life Sci; 2023 Sep; 329():121872. PubMed ID: 37352917
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Factors affecting adenoma detection rate in a national flexible sigmoidoscopy screening programme: a retrospective analysis.
    Bevan R; Blanks RG; Nickerson C; Saunders BP; Stebbing J; Tighe R; Veitch AM; Garrett W; Rees CJ
    Lancet Gastroenterol Hepatol; 2019 Mar; 4(3):239-247. PubMed ID: 30655218
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Investments in cancer research awarded to UK institutions and the global burden of cancer 2000-2013: a systematic analysis.
    Maruthappu M; Head MG; Zhou CD; Gilbert BJ; El-Harasis MA; Raine R; Fitchett JR; Atun R
    BMJ Open; 2017 Apr; 7(4):e013936. PubMed ID: 28428185
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma.
    Hu J; Xu Y; Cai S
    Eur J Med Res; 2015 Dec; 20():95. PubMed ID: 26626874
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung cancers.
    D'Haene N; Le Mercier M; De Nève N; Blanchard O; Delaunoy M; El Housni H; Dessars B; Heimann P; Remmelink M; Demetter P; Tejpar S; Salmon I
    PLoS One; 2015; 10(9):e0138245. PubMed ID: 26366557
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
    Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
    Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparative molecular field analysis of in vitro growth inhibition of L1210 and HCT-8 cells by some pyrazoloacridines.
    Horwitz JP; Massova I; Wiese TE; Wozniak AJ; Corbett TH; Sebolt-Leopold JS; Capps DB; Leopold WR
    J Med Chem; 1993 Nov; 36(23):3511-6. PubMed ID: 8280289
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.